FBTDX SEC Filings — Franklin Biotechnology Discovery Fund

Data updated: 2026-09-25

57 SEC filings are listed: 21 prospectuses (latest Aug 25, 2026), 28 quarterly N-PORT holdings reports (latest Sep 25, 2026), 7 annual N-CEN reports (latest Jul 10, 2026) and 1 N-CEN/A (latest Jul 13, 2023).

FBTDX Prospectus (485BPOS / 497)

Objective, strategy, fees and risks. 21 filings on SEC EDGAR.

FBTDX Portfolio holdings (N-PORT)

Full holdings and monthly flows, filed quarterly. 28 filings on SEC EDGAR.

FBTDX Annual census (N-CEN)

Service providers, brokerage and operations. 7 filings on SEC EDGAR.

FBTDX Annual census, amended (N-CEN/A) (N-CEN/A)

1 filing on SEC EDGAR.

Browse every Franklin Biotechnology Discovery Fund filing on SEC EDGAR

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, and annual data from Form N-CEN.

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.